• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Model Number S-65-040-120-P6
Device Problems Difficult or Delayed Activation (2577); Defective Device (2588); Malposition of Device (2616); Migration (4003)
Patient Problem Unspecified Vascular Problem (4441)
Event Date 12/29/2021
Event Type  Injury  
Manufacturer Narrative
The device is expected to be returned for evaluation.It has not yet been received.A follow up report will be submitted with all additional relevant information.The additional device referenced is being filed under a separate medwatch report number.
 
Event Description
It was reported that the procedure was to treat the proximal to mid superficial femoral artery.The vessel diameter was 6.3 mm and atherectomy was not performed.Pre-dilatation was performed with a 6x40 mm non-abbott balloon for 120 seconds at 24 atmospheres twice.The 6.5x40 mm supera self expanding stent system (sess) was advanced to the lesion and deployed; however, the stent began to shorten and slip out of place from the target lesion during deployment.Some of the stent went into healthy tissue while some remained in the target lesion.The physician stated it was possible the stent moved during deployment.Next, a 6.5x80 mm supera sess was advanced and was deployed.However, the stent elongated when the delivery system was removed and some went into healthy tissue, while some remained in the target lesion.It was attempted to retrieve the stent using a non-abbott sheath but the delivery system was stuck completely and failed to remove all of the stent and delivery system.The tip of the supera is damaged.Surgery was performed to retrieve the delivery system, stent and the first implanted stent as well.Final patient outcome is good.No additional information was provided.
 
Manufacturer Narrative
The device was returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.It is possible that during stent deployment interaction with the anatomy and/or the delivery system was slightly pushed distally as the stent was being deployed resulting in the stent to shorten and slip out of place from the target lesion; thus resulting in the reported stent migration and stent malposition into healthy tissue; however, this could not be confirmed.The investigation was unable to determine a conclusive cause for the reported difficulties.The treatment appears to be related to the operational context of the procedure as surgery was performed to retrieve the implanted stent.There is no indication of a product quality issue with respect to manufacture, design or labeling.D9/h3 - device return status changed from yes to no.
 
Event Description
N/a.
 
Manufacturer Narrative
The device was returned for analysis.The reported difficult or delayed activation was unable to be replicated in a testing environment due to the condition of the returned device.The reported defective device shortened was unable to be replicated in a testing environment as the stent was not returned.The reported migration and malposition of stent were unable to be replicated in a testing environment as they were based on operational circumstances.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.It is possible that during stent deployment interaction with the anatomy and/or the delivery system was slightly pushed distally as the stent was being deployed resulting in the stent to shorten and slip out of place from the target lesion; thus resulting in the reported stent migration and stent malposition into healthy tissue; however, this could not be confirmed.The investigation was unable to determine a conclusive cause for the reported difficulties.The treatment appears to be related to the operational context of the procedure as surgery was performed to retrieve the implanted stent.There is no indication of a product quality issue with respect to manufacture, design or labeling.H10: removed type of investigation code 4115 and added 10; removed investigation conclusion code 67 and added 4315; added investigation findings code 114.
 
Event Description
N/a.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key13308643
MDR Text Key284172983
Report Number2024168-2022-00686
Device Sequence Number1
Product Code NIP
UDI-Device Identifier08717648226229
UDI-Public08717648226229
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 04/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2022
Device Model NumberS-65-040-120-P6
Device Catalogue NumberS-65-040-120-P6
Device Lot Number1012161
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/29/2021
Initial Date FDA Received01/20/2022
Supplement Dates Manufacturer Received03/01/2022
03/29/2022
Supplement Dates FDA Received03/11/2022
04/20/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/21/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
DESTINATION 6FR 45CM
Patient Outcome(s) Required Intervention;
-
-